These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10556301)

  • 1. Detection of the survival motor neuron (SMN) genes by FISH: further evidence for a role for SMN2 in the modulation of disease severity in SMA patients.
    Vitali T; Sossi V; Tiziano F; Zappata S; Giuli A; Paravatou-Petsotas M; Neri G; Brahe C
    Hum Mol Genet; 1999 Dec; 8(13):2525-32. PubMed ID: 10556301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity.
    Harada Y; Sutomo R; Sadewa AH; Akutsu T; Takeshima Y; Wada H; Matsuo M; Nishio H
    J Neurol; 2002 Sep; 249(9):1211-9. PubMed ID: 12242541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.
    Wirth B; Brichta L; Schrank B; Lochmüller H; Blick S; Baasner A; Heller R
    Hum Genet; 2006 May; 119(4):422-8. PubMed ID: 16508748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust quantification of the SMN gene copy number by real-time TaqMan PCR.
    Gómez-Curet I; Robinson KG; Funanage VL; Crawford TO; Scavina M; Wang W
    Neurogenetics; 2007 Nov; 8(4):271-8. PubMed ID: 17647030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
    Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
    Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype.
    Sossi V; Giuli A; Vitali T; Tiziano F; Mirabella M; Antonelli A; Neri G; Brahe C
    Eur J Hum Genet; 2001 Feb; 9(2):113-20. PubMed ID: 11313744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
    Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
    Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings.
    Cuscó I; Barceló MJ; Rojas-García R; Illa I; Gámez J; Cervera C; Pou A; Izquierdo G; Baiget M; Tizzano EF
    J Neurol; 2006 Jan; 253(1):21-5. PubMed ID: 15981080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of SMN hybrid genes in Spanish SMA patients: de novo, homozygous and compound heterozygous cases.
    Cuscó I; Barceló MJ; del Rio E; Martín Y; Hernández-Chico C; Bussaglia E; Baiget M; Tizzano EF
    Hum Genet; 2001 Mar; 108(3):222-9. PubMed ID: 11354634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.
    Tran VK; Sasongko TH; Hong DD; Hoan NT; Dung VC; Lee MJ; Gunadi ; Takeshima Y; Matsuo M; Nishio H
    Pediatr Int; 2008 Jun; 50(3):346-51. PubMed ID: 18533950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
    Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
    Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.
    Monani UR; Pastore MT; Gavrilina TO; Jablonka S; Le TT; Andreassi C; DiCocco JM; Lorson C; Androphy EJ; Sendtner M; Podell M; Burghes AH
    J Cell Biol; 2003 Jan; 160(1):41-52. PubMed ID: 12515823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.
    Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB
    Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
    Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy.
    Andreassi C; Angelozzi C; Tiziano FD; Vitali T; De Vincenzi E; Boninsegna A; Villanova M; Bertini E; Pini A; Neri G; Brahe C
    Eur J Hum Genet; 2004 Jan; 12(1):59-65. PubMed ID: 14560316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.